T2 Biosystems, Inc. (TTOO)
(Delayed Data from NSDQ)
$2.03 USD
-0.19 (-8.56%)
Updated Mar 3, 2021 04:00 PM ET
Pre-Market: $2.03 0.00 (0.00%) 9:12 AM ET
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Zacks Rank | Definition | Annualized Return |
---|---|---|
1 | Strong Buy | 24.41% |
2 | Buy | 17.88% |
3 | Hold | 9.48% |
4 | Sell | 5.03% |
5 | Strong Sell | 1.87% |
S&P | 500 | 10.70% |
Zacks Rank Education - Learn about the Zacks Rank
Zacks Rank Home - Zacks Rank resources in one place
Zacks Premium - The only way to fully access the Zacks Rank
4-Sell of 5 4
The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.
The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.
Value Score | A |
---|---|
Growth Score | A |
Momentum Score | A |
VGM Score | A |
Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.
As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.
Zacks Style Scores Education - Learn more about the Zacks Style Scores
F Value C Growth A Momentum D VGM
The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.
An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.
The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.
Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank
Zacks News
T2 Biosystems (TTOO) Jumps: Stock Rises 8.7%
by Zacks Equity Research
T2 Biosystems (TTOO) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
HOLXPositive Net Change TTOONegative Net Change
medical
T2 Biosystems (TTOO) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
T2 Biosystems (TTOO) delivered earnings and revenue surprises of 20.00% and 32.45%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
TTOONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Will T2 Biosystems (TTOO) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
T2 Biosystems (TTOO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TTOONegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Is T2 Biosystems (TTOO) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (TTOO) Outperforming Other Medical Stocks This Year?
TTOONegative Net Change
momentum-stocks sectors stock-market-sectors
Is T2 Biosystems (TTOO) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (TTOO) Outperforming Other Medical Stocks This Year?
TTOONegative Net Change
momentum-stocks sectors stock-market-sectors
Is T2 Biosystems (TTOO) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (TTOO) Outperforming Other Medical Stocks This Year?
TTOONegative Net Change
momentum-stocks sectors stock-market-sectors
The Zacks Analyst Blog Highlights: TTOO, KMDA and CERS
by Zacks Equity Research
The Zacks Analyst Blog Highlights: TTOO, KMDA and CERS
CERSNo Net Change KMDAPositive Net Change TTOONegative Net Change
medical
3 Plasma Stocks to Win Big on FDA's Convalescent EUA
by Tirthankar Chakraborty
Convalescent plasma stocks moved northward following FDA's emergency plasma authorization for COVID-19 treatment. Here're three of them that should be on your watch list -
CERSNo Net Change KMDAPositive Net Change TTOONegative Net Change
biotechs medical
Is T2 Biosystems (TTOO) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (TTOO) Outperforming Other Medical Stocks This Year?
TTOONegative Net Change
momentum-stocks sectors stock-market-sectors
Do Options Traders Know Something About T2 Biosystems (TTOO) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to T2 Biosystems (TTOO) stock based on the movements in the options market lately.
TTOONegative Net Change
medical
T2 Biosystems (TTOO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, T2 Biosystems (TTOO) closed at $1.66, marking a +1.84% move from the previous day.
TTOONegative Net Change
daily-movers popular-stocks stocks-moving-today trending-companies trending-stocks trending-tickers
T2 Biosystems (TTOO) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
T2 Biosystems' (TTOO) second-quarter results are likely to reflect growth in product revenues.
HOLXPositive Net Change IARTNegative Net Change EXASNegative Net Change TTOONegative Net Change
earnings medical
T2 Biosystems (TTOO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, T2 Biosystems (TTOO) closed at $1.62, marking a +0.62% move from the previous day.
TTOONegative Net Change
daily-movers popular-stocks stocks-moving-today trending-companies trending-stocks trending-tickers
T2 Biosystems (TTOO) Stock Moves -0.75%: What You Should Know
by Zacks Equity Research
In the latest trading session, T2 Biosystems (TTOO) closed at $1.33, marking a -0.75% move from the previous day.
TTOONegative Net Change
daily-movers popular-stocks stocks-moving-today trending-companies trending-stocks trending-tickers
Company News for Jul 2, 2020
by Zacks Equity Research
Companies in the news are: M, FDX, BYND, TTOO
FDXNegative Net Change MPositive Net Change TTOONegative Net Change BYNDNegative Net Change
consumer-discretionary medical retail
Has T2 Biosystems (TTOO) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (TTOO) Outperforming Other Medical Stocks This Year?
TTOONegative Net Change
momentum-stocks sectors stock-market-sectors
Are Options Traders Betting on a Big Move in T2 Biosystems (TTOO) Stock?
by Zacks Equity Research
Investors need to pay close attention to T2 Biosystems (TTOO) stock based on the movements in the options market lately.
TTOONegative Net Change
medical
Has T2 Biosystems (TTOO) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (TTOO) Outperforming Other Medical Stocks This Year?
TTOONegative Net Change
momentum-stocks sectors stock-market-sectors
Company News for May 26, 2020
by Zacks Equity Research
Companies In The News Are: TTWO, XERS, SPLK, NAVB
SPLKNegative Net Change NAVBNo Net Change TTOONegative Net Change XERSNegative Net Change
medical
Is the Options Market Predicting a Spike in T2 Biosystems (TTOO) Stock?
by Zacks Equity Research
Investors need to pay close attention to T2 Biosystems (TTOO) stock based on the movements in the options market lately.
TTOONegative Net Change
medical
T2 Biosystems (TTOO) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
T2 Biosystems' (TTOO) first-quarter performance is likely to reflect growth in product revenues.
LMNXPositive Net Change HAENo Net Change TTOONegative Net Change ACBNegative Net Change
earnings medical
Is the Options Market Predicting a Spike in T2 Biosystems (TTOO) Stock?
by Zacks Equity Research
Investors need to pay close attention to T2 Biosystems (TTOO) stock based on the movements in the options market lately.
TTOONegative Net Change
medical pharmaceuticals
Analysts Estimate T2 Biosystems (TTOO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
T2 Biosystems (TTOO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TTOONegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Earnings Preview: T2 Biosystems (TTOO) Q3 Earnings Expected to Decline
by Zacks Equity Research
T2 Biosystems (TTOO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TTOONegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Are Options Traders Betting on a Big Move in T2 Biosystems (TTOO) Stock?
by Zacks Equity Research
Investors need to pay close attention to T2 Biosystems (TTOO) stock based on the movements in the options market lately.
TTOONegative Net Change
medical